Printer Friendly

A RADICAL plan to end [...].

A RADICAL plan to end the "madness" of wasteful and pointless research by rival drug companies has been outlined.

The new initiative will promote faster early stage drug development through collaboration.

Central to the idea is banishing the secrecy tied to intellectual property (IP) that causes the same work to be duplicated even after it has led nowhere. Earlier this month, about 30 academics, research funders and pharmaceutical industry representatives from around the world meet in Toronto, Canada, to hammer out plans for the new model.

The objective is to launch a prototype scheme by the end of the year at an estimated annual cost of about pounds 124m.

Neuroscientist Dr Chas Bountra, head of the Structural Genomics Consortium at Oxford University, who is organising the conference, believes the pharmaceutical industry is in crisis.

He said under the present system different organisations can spend many years chasing the same therapeutic targets.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Features
Publication:Evening Chronicle (Newcastle, England)
Date:Feb 21, 2011
Previous Article:AN ingredient in red wine [...].
Next Article:NHS doctors who qualify overseas [...].

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters